Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women

Clinical Microbiology and Infection

Volumn 12, Issue 9, 2006, Pages 927-930

  Finan, R R ^a   Musharrafieh, U ^b   Almawi, W Y ^c  

^a St Georges University Hospital   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

Cervical carcinoma; Chlamydia trachomatis; Herpes simplex virus; Human papilloma virus; Risk factors

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FUNGAL DETECTION; GENOTYPE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN TISSUE; INFECTION RISK; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVICITIS; UTERUS BIOPSY; VIRUS DETECTION; VIRUS INFECTION; VIRUS STRAIN; WART VIRUS;

CHLAMYDIA TRACHOMATIS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; SIMPLEXVIRUS;

EID: 33746596645     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01479.x     Document Type: Article

References (20)

1. Daling JR, Madeleine MM, Schwartz SM et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84: 263-270.
2. Lehtinen M, Koskela P, Jellum E et al. Herpes simplex virus and the risk of cervical cancer: A longitudinal nested-control 2002 study in Nordic countries. Am J Epidemiol 2003; 156: 687-692.
3. Smith JS, Herrero R, Bosetti C et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002; 94: 1604-1613.
4. Smith JS, Bosetti C, Munoz N et al. Chlamydia trachomatis and invasive cervical cancer: A pooled analysis of the IARC multicentric case-control study. Int J Cancer 2004; 111: 431-439.
5. Silins I, Ryd W, Strand A et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005; 116: 110-115.
6. Munoz N, Kato I, Bosch FX et al. Cervical cancer and herpes simplex virus type 2: Case control studies in Spain and Columbia with special reference to immunoglobulin-G subclasses. Int J Cancer 1995; 60: 438-442.
7. Jones C. Cervical cancer: Is herpes simplex virus type II a cofactor? Clin Microbiol Rev 1995; 8: 549-556.
8. Smith JS, Munoz N, Herrero R et al. Evidence for Chlamyda trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002; 185: 324-331.
9. Lehtinen M, Pawlita M, Zumbach K et al. Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1-20 years later. Am J Obstet Gynecol 2003; 188: 49-55.
10. Harnish DG, Belland LM, Scheid EE, Rohan TE. Evaluation of human papillomavirus - consensus primers for HPV detection by the polymerase chain reaction. Mol Cell Probes 1999; 13: 9-21.
11. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995; 171: 857-863.
12. Koskela P, Anttila T, Bjorge T et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000; 85: 35-39.
13. Bosh FX, Manos MM, Munos N. Prevalence of human papillomavirus in cervical cancer: A world wide perspective. J Natl Cancer Inst 1995; 8: 796-802.
14. Mroueh S, Seoud MA, Kaspar HG, Zalloua PA. Prevalence of genital papillomavirus among Lebanese women. Eur J Gynecol Oncol 2002; 23: 424-432.
15. Wu CH, Lee MF, Chang MC, Ho SC. Detection of human papillomavirus types in cervical lesions of patients from Taiwan by polymerase chain reaction. Sex Transm Dis 1994; 21: 309-314.
16. Olsen AO, Orstavik I, Dillar J, Vestergaard BF, Magnus P. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade 11-111. APMIS 1998; 106: 417-424.
17. Lowhagen GB, Tunback P, Bergstrom T. Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HDS isolates. Acta Derm Venereol 2002; 82: 118-120.
18. Xu F, Schillinger JA, Sternberg MR et al. Seroprevalence and co-infection with herpes simplex virus type 1 and 2 in the United States 1988-1994. J Infect Dis 2002; 185: 1019-1024.
19. Stanberry LR, Spruance SL, Cunningham AL et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002; 347: 1652-1061.
20. Gervassi A, Alderson MR, Suchland R, Maisonneuve JF, Grabstein KH, Probst P. Differential regulation of inflammatory cytokine secretion by human dendritic cells upon Chlamydia trachomatis infection. Infect Immun 2004; 72: 7231-7239.